News

The allowed claims for US Patent Application No. 12/528,690 entitled ‘Composition and Methods for Modulating Cell Proliferation and Cell Death’, cover a core element of Rosetta Genomics’ microRNA

The patent covers the company’s carbohydrate-based galectin inhibitor compound GR-MD-02 for use in patients with fatty liver disease with or without fibrosis or cirrhosis, providing patent protection through

The patent covers all of the company’s therapeutic antibodies, and can also be applied to most other antibodies, permitting a concentrated formulation to be given in low volume

The company is replacing a mix of highly customized solutions built on an outdated legacy platform with Veeva Systems’ suite of applications, spanning from clinical to commercial. The

In June 2013, the three parties have collaborated on to build the new center to address increasing demand from pharmaceutical and other Iife science companies for comprehensive imaging

Primary endpoint of the trial is reduction in the Ulcerative Colitis Disease Activity Index (UCDAI) at six weeks, while secondary endpoints include endoscopic remission, reduction in UCDAI at

Phosgene, which is classified as a toxic industrial chemical, is currently used to make chemicals and pesticides. At room temperature Phosgene is a poisonous gas and poses a

VS-4718 is an oral compound that is designed to target cancer stem cells via the potent inhibition of focal adhesion kinase (FAK). The company said that cancer stem

MONOVISC is a single injection supplement to synovial fluid of the osteoarthritic joint, indicated to treat pain and improve joint mobility in these patients who have failed to